Ferguson Enterprises Inc. ( FERG) Q4 2025 Earnings Call February 24, 2026 8:30 AM EST Hello, and welcome, everyone, to the Ferguson's Results for the Year Ended December 31, 2025, Earnings and the ...
Q4 2025 Earnings Call February 24, 2026 8:00 AM ESTCompany ParticipantsGraham Stanley - VP of Investor Relations & ...
Cardinal’s 2025 year-end reserves reflect the quality, predictability, and sustainability of our low decline conventional asset base which is now being supplemented and enhanced by the growing ...
SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for ...
Coeur Mining, Inc. (NYSE:CDE) Q4 2025 Earnings Call Transcript February 19, 2026 Operator: Good day, and welcome to the Coeur ...
Herbalife Nutrition Ltd. (NYSE:HLF) Q4 2025 Earnings Call Transcript February 19, 2026 Operator: Welcome, and thank you for joining the fourth quarter and full year 2025 earnings conference call for ...
Our distribution partners are also signaling concern about supply availability as inventories remain low, an environment that ...
M2i Global Inc (OTC:MTWO) announced that it and Volato Group (NYSE:SOAR) have entered a Strategic Collaboration Agreement with SMX (NASDAQ:SMX), a company focused on supply chain traceability and ...
Lundin Gold Inc. ("Lundin Gold" or the "Company") today announced its financial results for the fourth quarter and year ended ...
Record 4Q and Full Year Performance at Work Truck Solutions; Record Parts & Accessories Sales at Work Truck Attachments Full Year 2025 Highlights* Consolidated Net Sales increased 15.4% to $656.1 mill ...
The Board of Directors also approved and declared a quarterly cash dividend of $0.295 per share for the first quarter of 2026. The declared dividend will be paid on March 31, 2026, to stockholders of ...
Takeda (TSE:4502/NYSE:TAK) today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer the possibility of clinical remission for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results